Idexx Laboratories (IDXX) Accumulated Expenses (2009 - 2026)

Idexx Laboratories' Accumulated Expenses history runs 18 years deep, the most recent figure standing at $453.6 million for Q1 2026.

• In Q1 2026, Accumulated Expenses fell 7.57% year-over-year to $453.6 million; the TTM figure through Mar 2026 stood at $453.6 million (down 7.57% YoY), while the FY2025 annual figure was $530.1 million, up 5.58% from the prior year.
• Accumulated Expenses was $453.6 million for Q1 2026 at Idexx Laboratories, down from $530.1 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $541.1 million in Q2 2024 to a low of $387.5 million in Q2 2022.
• Historically, Accumulated Expenses has averaged $455.9 million across 5 years, with a median of $453.6 million in 2026.
• The sharpest annual moves came in 2024 and 2025: Accumulated Expenses soared 35.48% in 2024, then declined 22.94% in 2025.
• A 5-year view of Accumulated Expenses shows it stood at $433.7 million in 2022, then gained by 10.39% to $478.7 million in 2023, then advanced by 4.89% to $502.1 million in 2024, then gained by 5.58% to $530.1 million in 2025, then slipped by 14.45% to $453.6 million in 2026.
• The last three Accumulated Expenses figures came in at $453.6 million (Q1 2026), $530.1 million (Q4 2025), and $488.9 million (Q3 2025), per Business Quant data.